A case of celecoxib-induced multiple ulcers of the small intestine observed on capsule endoscopy

Yuki Aoyama, Sakuma Takahashi, Tomoki Inaba, Mariko Colvin, Shigenao Ishikawa, Masaki Wato, Yoshiyasu Kono, Seiji Kawano, Akinobu Takaki, Hiroyuki Okada

Research output: Contribution to journalArticle

Abstract

The patient was a 75-year-old man with melena. Capsule endoscopy revealed colonic diverticular bleeding as well as 2-to 3-mm erosions scattered in the small intestine. The colonic diverticular bleeding was treated by endoscopic clipping. Two months later, administration of celecoxib was started for knee pain. Nine months later, black stools and iron-deficiency anemia were observed, and multiple ulcers were found in the intestine on capsule endoscopy. The patient was diagnosed as having nonsteroidal anti-inflammatory drug-induced small intestinal ulcer. The cele-coxib therapy was discontinued, and administration of misoprostol, rebamipide, and polaprezinc was started. Capsule endoscopy performed three months after starting the treatment demonstrated improvement of the ulcers. Celecoxib is a cyclooxygenase-2 (COX-2) selective inhibitor and is considered to confer a low risk of mucosal injury, but the risk of mucosal injury may increase with chronic administration of celecoxib or combination therapy with a proton pump inhibitor. Therefore, careful attention should be paid to patients who are being treated with celecoxib.

LanguageEnglish
Pages2297-2302
Number of pages6
JournalGASTROENTEROLOGICAL ENDOSCOPY
Volume60
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Celecoxib
Capsule Endoscopy
Small Intestine
Ulcer
polaprezinc
Hemorrhage
Melena
Misoprostol
Iron-Deficiency Anemias
Proton Pump Inhibitors
Cyclooxygenase 2 Inhibitors
Wounds and Injuries
Intestines
Knee
Anti-Inflammatory Agents
Therapeutics
Pain
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

A case of celecoxib-induced multiple ulcers of the small intestine observed on capsule endoscopy. / Aoyama, Yuki; Takahashi, Sakuma; Inaba, Tomoki; Colvin, Mariko; Ishikawa, Shigenao; Wato, Masaki; Kono, Yoshiyasu; Kawano, Seiji; Takaki, Akinobu; Okada, Hiroyuki.

In: GASTROENTEROLOGICAL ENDOSCOPY, Vol. 60, No. 10, 01.10.2018, p. 2297-2302.

Research output: Contribution to journalArticle

Aoyama, Yuki ; Takahashi, Sakuma ; Inaba, Tomoki ; Colvin, Mariko ; Ishikawa, Shigenao ; Wato, Masaki ; Kono, Yoshiyasu ; Kawano, Seiji ; Takaki, Akinobu ; Okada, Hiroyuki. / A case of celecoxib-induced multiple ulcers of the small intestine observed on capsule endoscopy. In: GASTROENTEROLOGICAL ENDOSCOPY. 2018 ; Vol. 60, No. 10. pp. 2297-2302.
@article{0db495cc969b47c4bd5167d1b21635b8,
title = "A case of celecoxib-induced multiple ulcers of the small intestine observed on capsule endoscopy",
abstract = "The patient was a 75-year-old man with melena. Capsule endoscopy revealed colonic diverticular bleeding as well as 2-to 3-mm erosions scattered in the small intestine. The colonic diverticular bleeding was treated by endoscopic clipping. Two months later, administration of celecoxib was started for knee pain. Nine months later, black stools and iron-deficiency anemia were observed, and multiple ulcers were found in the intestine on capsule endoscopy. The patient was diagnosed as having nonsteroidal anti-inflammatory drug-induced small intestinal ulcer. The cele-coxib therapy was discontinued, and administration of misoprostol, rebamipide, and polaprezinc was started. Capsule endoscopy performed three months after starting the treatment demonstrated improvement of the ulcers. Celecoxib is a cyclooxygenase-2 (COX-2) selective inhibitor and is considered to confer a low risk of mucosal injury, but the risk of mucosal injury may increase with chronic administration of celecoxib or combination therapy with a proton pump inhibitor. Therefore, careful attention should be paid to patients who are being treated with celecoxib.",
author = "Yuki Aoyama and Sakuma Takahashi and Tomoki Inaba and Mariko Colvin and Shigenao Ishikawa and Masaki Wato and Yoshiyasu Kono and Seiji Kawano and Akinobu Takaki and Hiroyuki Okada",
year = "2018",
month = "10",
day = "1",
doi = "10.11280/gee.60.2297",
language = "English",
volume = "60",
pages = "2297--2302",
journal = "Gastroenterological Endoscopy",
issn = "0387-1207",
publisher = "Japan Gastroenterological Endoscopy Society",
number = "10",

}

TY - JOUR

T1 - A case of celecoxib-induced multiple ulcers of the small intestine observed on capsule endoscopy

AU - Aoyama, Yuki

AU - Takahashi, Sakuma

AU - Inaba, Tomoki

AU - Colvin, Mariko

AU - Ishikawa, Shigenao

AU - Wato, Masaki

AU - Kono, Yoshiyasu

AU - Kawano, Seiji

AU - Takaki, Akinobu

AU - Okada, Hiroyuki

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The patient was a 75-year-old man with melena. Capsule endoscopy revealed colonic diverticular bleeding as well as 2-to 3-mm erosions scattered in the small intestine. The colonic diverticular bleeding was treated by endoscopic clipping. Two months later, administration of celecoxib was started for knee pain. Nine months later, black stools and iron-deficiency anemia were observed, and multiple ulcers were found in the intestine on capsule endoscopy. The patient was diagnosed as having nonsteroidal anti-inflammatory drug-induced small intestinal ulcer. The cele-coxib therapy was discontinued, and administration of misoprostol, rebamipide, and polaprezinc was started. Capsule endoscopy performed three months after starting the treatment demonstrated improvement of the ulcers. Celecoxib is a cyclooxygenase-2 (COX-2) selective inhibitor and is considered to confer a low risk of mucosal injury, but the risk of mucosal injury may increase with chronic administration of celecoxib or combination therapy with a proton pump inhibitor. Therefore, careful attention should be paid to patients who are being treated with celecoxib.

AB - The patient was a 75-year-old man with melena. Capsule endoscopy revealed colonic diverticular bleeding as well as 2-to 3-mm erosions scattered in the small intestine. The colonic diverticular bleeding was treated by endoscopic clipping. Two months later, administration of celecoxib was started for knee pain. Nine months later, black stools and iron-deficiency anemia were observed, and multiple ulcers were found in the intestine on capsule endoscopy. The patient was diagnosed as having nonsteroidal anti-inflammatory drug-induced small intestinal ulcer. The cele-coxib therapy was discontinued, and administration of misoprostol, rebamipide, and polaprezinc was started. Capsule endoscopy performed three months after starting the treatment demonstrated improvement of the ulcers. Celecoxib is a cyclooxygenase-2 (COX-2) selective inhibitor and is considered to confer a low risk of mucosal injury, but the risk of mucosal injury may increase with chronic administration of celecoxib or combination therapy with a proton pump inhibitor. Therefore, careful attention should be paid to patients who are being treated with celecoxib.

UR - http://www.scopus.com/inward/record.url?scp=85055492920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055492920&partnerID=8YFLogxK

U2 - 10.11280/gee.60.2297

DO - 10.11280/gee.60.2297

M3 - Article

VL - 60

SP - 2297

EP - 2302

JO - Gastroenterological Endoscopy

T2 - Gastroenterological Endoscopy

JF - Gastroenterological Endoscopy

SN - 0387-1207

IS - 10

ER -